McDermott Will & Emery’s LifeScience Dealmaking Symposium

November 5, 2024

Boston, MA

  Overview:

Outcome Capital‘s Ellen Baron, PhD will be speaking at McDermott Will & Emery‘s #LifeScience #Dealmaking Symposium in Boston on November 5th. Don’t miss her insights on:
– Pulse of the #Biopharma and #Medtech Industry 2023/2024
– Notable Development in 2024: Headwinds and Tailwinds
– Trends of #IPOs, #Mergers & #Acquisitions, #VC #funding
– 2025 Industry Outlook
If you are attending and want to discuss current market trends and transactional dynamics, reach out to Ellen to find time to talk.
News

Outcome Capital Continues to Expand with the Addition of Charles Simmons

Appointment of Charles Simmons as Managing Director continues to strengthen Outcome’s capabilities

Read More
Resources

Outcome Capital Life Science Market Pulse, October 2024

Outcome Capital Life Science Market Pulse October 2024 Click to view our LifeSciences Pulse Newsletter

Download

Contact Us for More Information

Would you like to learn more about working with Outcome Capital or discuss your specific needs?

Contact Us

  • Boston

    20 Custom House St, Suite 1200, Boston, MA 02110
    (617) 431-2278

© Outcome Capital 2024. Member of Financial Industry Regulatory Authority (FINRA) and the Securities Investment Protection Corporation (SIPC). Check the background of this firm on FINRA’s BrokerCheck.

Business Continuity Plan | Privacy Policy | Regulation Best Interest

Built by Metropolis